398 related articles for article (PubMed ID: 23909871)
21. Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus.
Han JY; Choi DH; Choi SW; Kim BB; Ki YJ; Chung JW; Koh YY; Chang KS; Hong SP
Platelets; 2013; 24(5):401-6. PubMed ID: 22871068
[TBL] [Abstract][Full Text] [Related]
22. Mean Platelet Volume and Major Adverse Cardiac Events following Percutaneous Coronary Intervention.
Nozari Y; Parsa M; Jalali A; Ariannejad H; Shafiee A
Arch Iran Med; 2019 Apr; 22(4):198-203. PubMed ID: 31126178
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention.
Goncalves SC; Labinaz M; Le May M; Glover C; Froeschl M; Marquis JF; O'Brien E; Shukla D; Ruchin P; Sookur D; Ha A; So D
Am J Cardiol; 2011 Jan; 107(2):204-9. PubMed ID: 21129717
[TBL] [Abstract][Full Text] [Related]
24. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting.
Jin HY; Yang TH; Kim DI; Chung SR; Seo JS; Jang JS; Kim DK; Kim DK; Kim KH; Seol SH; Nam CW; Hur SH; Kim W; Park JS; Kim YJ; Kim DS
Int J Cardiol; 2013 Sep; 167(5):1877-81. PubMed ID: 22682702
[TBL] [Abstract][Full Text] [Related]
25. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Thromb Haemost; 2010 Aug; 104(2):279-86. PubMed ID: 20508896
[TBL] [Abstract][Full Text] [Related]
26. Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction.
Tian C; Song J; He D; Wu J; Sun Z; Sun Z
Int Heart J; 2018 Mar; 59(2):286-292. PubMed ID: 29563382
[TBL] [Abstract][Full Text] [Related]
27. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of Mean Platelet Volume to Predict Significant Coronary Artery Disease in Patients With Non-ST-Elevation Acute Coronary Syndromes.
Taskesen T; Sekhon H; Wroblewski I; Goldfarb M; Ahmad MB; Nguyen QT; Fughhi IA; Gidron A; Dadkhah S
Am J Cardiol; 2017 Jan; 119(2):192-196. PubMed ID: 27814786
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of brachial-ankle pulse wave velocity for long-term clinical outcomes after percutaneous coronary intervention in a Korean cohort.
Ki YJ; Choi DH; Lee YM; Lim L; Song H; Koh YY
Int J Cardiol; 2014 Aug; 175(3):554-9. PubMed ID: 25015023
[TBL] [Abstract][Full Text] [Related]
30. Mean platelet volume is associated with culprit lesion severity and cardiac events in acute coronary syndromes without ST elevation.
Dogan A; Aksoy F; Icli A; Arslan A; Varol E; Uysal BA; Ozaydin M; Erdogan D
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):324-30. PubMed ID: 22473051
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
[TBL] [Abstract][Full Text] [Related]
32. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
Patti G; Nusca A; Mangiacapra F; Gatto L; D'Ambrosio A; Di Sciascio G
J Am Coll Cardiol; 2008 Sep; 52(14):1128-33. PubMed ID: 18804738
[TBL] [Abstract][Full Text] [Related]
33. Mean platelet volume and its prognostic value in acute coronary syndrome complicated by cardiogenic shock.
Supel K; Salska A; Jaskiewicz F; Kacprzak M; Zielinska M
Cardiol J; 2013; 20(3):254-60. PubMed ID: 23788299
[TBL] [Abstract][Full Text] [Related]
34. Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study.
Huczek Z; Filipiak KJ; Kochman J; Michalak M; Roik M; Piatkowski R; Grabowski M; Postula M; Opolski G
Thromb Res; 2010 May; 125(5):406-12. PubMed ID: 19786298
[TBL] [Abstract][Full Text] [Related]
35. Improved predictive value of GRACE risk score combined with platelet reactivity for 1-year cardiovascular risk in patients with acute coronary syndrome who underwent coronary stent implantation.
Li S; Liu H; Liu J; Wang H
Platelets; 2016 Nov; 27(7):650-657. PubMed ID: 27809713
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention.
Seyyed-Mohammadzad MH; Eskandari R; Rezaei Y; Khademvatani K; Mehrpooya M; Rostamzadeh A; Zahedi A
Anatol J Cardiol; 2015 Jan; 15(1):25-30. PubMed ID: 25179882
[TBL] [Abstract][Full Text] [Related]
37. Differential prognostic impact of high on-treatment platelet reactivity among patients with acute coronary syndromes versus stable coronary artery disease undergoing percutaneous coronary intervention.
Park DW; Ahn JM; Song HG; Lee JY; Kim WJ; Kang SJ; Yun SC; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
Am Heart J; 2013 Jan; 165(1):34-42.e1. PubMed ID: 23237131
[TBL] [Abstract][Full Text] [Related]
38. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
39. Point-of-care testing of clopidogrel-mediated platelet inhibition and risk for cardiovascular events after coronary angiography with or without percutaneous coronary intervention.
Holm M; Dalén M; Tornvall P; van der Linden J
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):577-84. PubMed ID: 24614428
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
